ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,995.54
      0.38%
      US Tech 100
      20,561.20
      0.10%
      Dow Jones
      43,988.99
      0.59%
      Brent Oil
      73.885
      -2.09%
      Bitcoin
      76,529.87
      0.83%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Arbutus Biopharma Corporation (ABUS)

      7. Arbutus Biopharma Corporation (ABUS) News

      Arbutus Biopharma Corporation

      Arbutus Biopharma Corporation (ABUS)

      NASDAQ
      3.75
      0.02
      (0.54%)
      At close: November 08 4:00PM
      Delayed by 15 minutes
      3.75
      -0.005
      ( -0.13% )
      After Hours: 4:49PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      ABUS News

      Official News Only

      Form S-3 - Registration statement under Securities Act of 1933
      Edgar (US Regulatory)
      November 06 2024
      ABUS (0.54%)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      November 06 2024
      ABUS (0.54%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      November 06 2024
      ABUS (0.54%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      October 15 2024
      ABUS (0.54%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      October 11 2024
      ABUS (0.54%)

      Form S-8 - Securities to be offered to employees in employee benefit plans
      Edgar (US Regulatory)
      August 08 2024
      ABUS (0.54%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      August 05 2024
      ABUS (0.54%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      August 01 2024
      ABUS (0.54%)

      ABUS Discussion

      View Posts
      mick mick 2 weeks ago
      👍️0
      db7 db7 3 weeks ago
      2 late breakers for AASLD: https://investor.arbutusbio.com/news-releases/news-release-details/arbutus-announces-multiple-abstracts-highlighting-imdusiran-data
      👍️0
      mick mick 2 months ago
      https://www.stockscores.com/charts/charts/?ticker=ABUS
      👍️0
      mick mick 2 months ago
      ABUS
      Arbutus Biopharma Corporation
      4.5488
      0.0388 (0.86%)
      Volume: 1,579,948
      Day Range: 4.39 - 4.56
      Last Trade Time: 7:46:00 PM EDT
      👍️0
      db7 db7 2 months ago
      breaking out; dare i say 'someone' knows 'something'(?)
      👍️0
      db7 db7 2 months ago
      ARBUTUS PHARMA CORP. et al v. PFIZER INC. et al "Please take notice that an in-person Markman Hearing is hereby scheduled for 12/18/2024 at 10:30AM in Trenton- Courtroom 4W. So Ordered by Judge Zahid N. Quraishi on 9/3/2024. (kas)"
      👍️0
      db7 db7 2 months ago
      ABUS over $4
      👍️0
      Monksdream Monksdream 2 months ago
      ABUS under $4
      👍️0
      DewDiligence DewDiligence 3 months ago
      ABUS pares pipeline–reduces workforce 40%:

      https://finance.yahoo.com/news/arbutus-reports-second-quarter-2024-113000099.html

      The company’s will focus on clinical development of Imdusiran regimens for HBV, but will terminate research on new HBV compounds.

      Oddly (for the reason mentioned at the bottom of #msg-174556022), ABUS opted to retain its oral PD-1 program.
      👍️0
      Rockurstocks Rockurstocks 4 months ago
      Not for long! $ABUS$
      👍️0
      Monksdream Monksdream 4 months ago
      ABUS under $4
      👍️0
      mick mick 4 months ago
      ABUS
      Arbutus Biopharma Corporation
      3.645
      -0.135 (-3.57%)
      Volume: 449,700
      Day Range: 3.645 - 3.845
      Last Trade Time: 2:29:04 PM EDT
      👍️0
      Monksdream Monksdream 4 months ago
      ABUS new 52/week high
      👍️0
      db7 db7 4 months ago
      👍️0
      db7 db7 5 months ago
      https://www.sec.gov/Archives/edgar/data/1447028/000089542124000390/ArbutusABUS.txt
      👍️0
      db7 db7 5 months ago
      New Presentation: https://investor.arbutusbio.com/static-files/f33bde13-92b8-48c4-a40e-36cf6dd25852
      👍️0
      db7 db7 5 months ago
      Poster for EASL https://www.arbutusbio.com/wp-content/uploads/2024/06/WED-371-Yuen-et-al-AB-729-201-IFN-poster-EASL-2024_FINAL.pdf
      👍️0
      mick mick 5 months ago
      ABUS
      Arbutus Biopharma Corporation
      3.341
      -0.019 (-0.57%)
      Volume: 534,638
      Day Range: 3.30 - 3.385
      Last Trade Time: 12:14:00 PM EDT
      Delayed by 15 minutes
      👍️0
      db7 db7 6 months ago
      EASL June 6-8th:
      https://investor.arbutusbio.com/news-releases/news-release-details/arbutus-present-imdusiran-data-easl-congress-2024

      "
      HBsAg = LLOQ (lower limit of quantification) with detectable anti-HBs was observed at end-of-treatment in 28% of subjects who received 4 or 6 doses of imdusiran plus 24 weeks of IFN
      "
      👍️0
      db7 db7 6 months ago
      Arbutus is waking up a little following yesterday's Motion to Dismiss with Acuitas:
      https://www.law360.com/ip/articles/1839088/judge-tosses-acuitas-covid-biotech-ip-suit-

      other important events of late include:

      1) company stating they have stopped their ATM and don't see a need to use it the rest of this year

      2) the Markman order against Moderna that went in their favor:
      https://investor.arbutusbio.com/news-releases/news-release-details/arbutus-biopharma-announces-claim-construction-ruling-its

      3) Activist becoming involved:
      https://www.morningstar.com/news/business-wire/20240517970994/whitefort-capital-publishes-open-letter-to-arbutus-biopharma-shareholders-outlining-paths-to-maximize-value
      👍️0
      db7 db7 6 months ago
      issue here, now, might be too many open $3 calls? will mm's hold her under....
      👍️0
      db7 db7 6 months ago
      mgmt killed this stock with that ATM; imo, used in a suspicious manner... ie: they put a lid on her on the markman order release at $3ish .. WHY would you do that? They could have raised same money at double the price
      👍️0
      MWM MWM 6 months ago
      Nice!
      👍️0
      db7 db7 6 months ago
      https://www.businesswire.com/news/home/20240517970994/en/
      👍️0
      db7 db7 6 months ago
      from Whitefort's 13D filed today: "The Reporting Persons have conveyed their view to the Issuer’s Board of Directors (the “Board”) that the current market price of the Shares does not reflect the Issuer’s intrinsic value. The Reporting Persons have requested that the Board immediately terminate the Issuer’s ATM program and explore all strategic options for the Issuer’s hepatitis B virus (HBV) portfolio. The Reporting Persons hope to continue to work constructively and collaboratively with the Board on these critical initiatives and intend to actively engage with shareholders and others regarding their views."
      👍️0
      Monksdream Monksdream 6 months ago
      ABUS under $3
      👍️0
      mick mick 7 months ago
      TWTR
      Twitter Inc
      53.70
      0.00 (0.00%)
      Volume:
      👍️0
      Monksdream Monksdream 7 months ago
      ABUS new 52 hi
      👍️0
      db7 db7 7 months ago
      looking a little better today; i guess it's going to be slow and steady and not the rocket on markman day like i hoped. i think this is looking really good med-long term on the litigation from after that markman ruling

      also, looking forward to EASL in june
      👍️0
      mick mick 7 months ago
      ABUS
      Arbutus Biopharma Corporation
      3.00
      0.08 (2.74%)
      Volume: 1,253,240
      Day Range: 2.86 - 3.11
      Bid: 2.99
      Ask: 3.00
      Last Trade Time: 9:56:51 AM EDT
      Total Trades: 3,890
      👍️0
      mick mick 7 months ago
      ABUS
      Arbutus Biopharma Corporation
      3.00
      0.08 (2.74%)
      Volume: 1,253,240
      Day Range: 2.86 - 3.11
      Bid: 2.99
      Ask: 3.00
      Last Trade Time: 9:56:51 AM EDT
      Total Trades: 3,890
      👍️0
      mick mick 7 months ago
      Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
      03/05/2024 04:48:49 PM
      👍️0
      mick mick 7 months ago
      Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
      03/05/2024 04:48:49 PM
      👍️0
      mick mick 7 months ago
      Arbutus to Participate in Two Upcoming Investor Conferences
      03/08/2024 07:30:00 AM
      Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
      03/05/2024 04:48:49 PM
      👍️0
      mick mick 7 months ago
      Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
      04/04/2024 08:30:49 AM
      Arbutus to Participate in Two Upcoming Investor Conferences
      03/08/2024 07:30:00 AM
      Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
      03/05/2024 04:48:49 PM
      👍️0
      Paullee Paullee 7 months ago
      07:15 AM EDT, 04/04/2024 (MT Newswires) -- A US court ruled against Moderna (MRNA) in a patent infringement case by Arbutus (ABUS) over its COVID-19 vaccines, Reuters reported Wednesday.

      US District Judge Mitchell Goldberg interpreted the patents in ways that favored Arbutus' case and hurt Moderna', Reuters reported.

      Arbutus sued Moderna in 2022, claiming the company's COVID-19 vaccine impinged on its patents for lipid nanoparticles that shield the vaccine's mRNA from the body's immune system.

      Moderna and Arbutus did not immediately respond to MT Newswires' requests for comment.
      👍️0
      MWM MWM 7 months ago
      Watching all 3 stocks. $ABUS is kind of moving...
      👍️0
      db7 db7 7 months ago
      was going to take all '3' to explode imo..
      👍️0
      MWM MWM 7 months ago
      Yes, I'm trying to read it myself
      👍️0
      db7 db7 7 months ago
      decision is out; looks like arbutus won '2' and moderna '1' .. please confirm
      👍️0
      db7 db7 8 months ago
      https://dailycaller.com/2024/03/14/drew-johnson-moderna-covid-vax-patent-infringement-biden-admin/
      👍️ 1
      Desert dweller Desert dweller 9 months ago
      My bad on post a few weeks ago. When I posted about $MRNA cash position, I didn't do the research I should have done and used what was on cash flow statement and didn't look into long term investments, very sloppy of me. Sorry about that.

      In today's release, they are projecting to use $4.3 billion of their cash plus investments during 2024. At 12/31/23 they reported cash plus LT investments of $13.3 billion and project about $9 billion at end of 2024. It will take longer than I thought for them to run out of cash and hopefully $ABUS takes a huge chunk of it. Today MRNA had a surprise profit, and I am still hoping that $ABUS finally cleans their clock for their blatant theft of IP.
      👍️ 1
      Desert dweller Desert dweller 9 months ago
      Handle on twitter is @DesertDweller93
      👍️0
      MWM MWM 9 months ago
      Great post!

      What’s your handle on Twitter?
      👍️0
      Desert dweller Desert dweller 9 months ago
      I've been saying on X for a month or so that $MRNA will be suffering a drop once it becomes known that they have roughly a year's worth of cash left, I just discovered this recently. They are burning almost $7 billion/year and they will report less than that at 12/31/23. That on top of the fact that during the past 3 years, they spent $7 billion in buybacks at prices much higher than current prices, all the way up to $300+. My prediction is major restructuring or significant secondary very soon. I bet they wish they had that cash now instead of overpriced treasury stock but then mgt wouldn't have been able to sell at those inflated covid prices.

      Hope $ABUS puts them into bankruptcy, the f'n thieves and I hope ABUS cleans $PFE and Biontech's clock too. They all know they are stealing the tech and just don't care. About time David kicks Goliath's ass again.
      👍️0
      MWM MWM 9 months ago
      A couple bad headlines for MRNA of late. Here is one of todays...

      Moderna’s RSV Vaccine May Lose Efficacy Faster Than GSK and Pfizer’s
      👍️0
      db7 db7 9 months ago
      yes, quite the drop yesterday and today on mrna... g/l!
      👍️0
      MWM MWM 9 months ago
      Puts on $MRNA might be the best play. If they have to pay up to $ABUS I have a feeling it might see a precipitous drop...

      MRNA bad news is piling up there...
      👍️0
      db7 db7 9 months ago
      https://twitter.com/themightyforego/status/1755757415750865356?s=46
      👍️0
      MWM MWM 9 months ago
      And also

      Get on Twitter Damn it lol!
      👍️0

      Your Recent History

      NASDAQ
      ABUS
      Arbutus Biopharma
      USOTC
      CYJBY
      Cargotec OYJ (PK)
      Delayed Upgrade Clock